Genetic Association of Single Nucleotide Polymorphisms in P53 Pathway with Gastric Cancer Risk

Strategic Insights -

A recent study on the P53 pathway has shed new light on the genetic factors that contribute to gastric cancer risk. Researchers at Capital Medical University in Beijing, China, analyzed single nucleotide polymorphisms (SNPs) in the P53 pathway to determine their association with gastric cancer in a hospital-based Chinese Han population. The study found that polymorphisms of P53 (rs1042522) and MDM2 (rs2279744) are associated with an increased risk of gastric cancer, while no significant association was observed between variant genotypes of MDM4 (rs1380576) and Hausp (rs1529916) and gastric cancer risk.

Key Takeaways:

  • The P53 tumor suppressor gene plays a crucial role in carcinogenesis and is central in reducing cancer frequency and mediating cancer therapy responses.
  • MDM2, MDM4, and Hausp genes are critical regulators of the P53 pathway and are involved in cancer risk and response to therapy.
  • The study analyzed the association of SNPs in P53 (rs1042522), MDM2 (rs2279744), MDM4 (rs1380576), and Hausp (rs1529916) genes with gastric cancer risk in a hospital-based Chinese Han population.
  • The study found a significant association between polymorphisms of P53 (rs1042522) and MDM2 (rs2279744) and gastric cancer risk.
  • The study found no significant association between variant genotypes of MDM4 (rs1380576) and Hausp (rs1529916) and gastric cancer risk.
  • The study provides new insights into the genetic factors that contribute to gastric cancer risk and highlights the potential of SNPs in P53 pathway as biomarkers for gastric cancer risk.
  • The Cancer Weekly reports that this research was published in the Journal of Medical Oncology in 2015.

Statistics:

  • 642 cases of gastric cancer and 720 cancer-free controls were analyzed in the study.
  • The study found a significant association between polymorphisms of P53 (rs1042522) and gastric cancer risk, with an odds ratio (OR) of 1.45 (95% CI: 1.14-1.84).
  • The study found a significant association between polymorphisms of MDM2 (rs2279744) and gastric cancer risk, with an OR of 1.52 (95% CI: 1.17-1.98).
  • The study found no significant association between variant genotypes of MDM4 (rs1380576) and gastric cancer risk, with an OR of 1.05 (95% CI: 0.82-1.34).
  • The study found no significant association between variant genotypes of Hausp (rs1529916) and gastric cancer risk, with an OR of 1.03 (95% CI: 0.80-1.32).

Sources:

  • Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population. Medical Oncology, 2015;32(1):488-492.
  • NewsRx LLC. News article on Cancer Weekly, 2015.